The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression
Clinical depression is a common, debilitating and heterogenous disorder. Existing treatments for depression are inadequate for a significant minority of patients and new approaches are urgently needed. A wealth of evidence implicates the serotonin 1A (5-HT1A) receptor in the pathophysiology of depre...
主要な著者: | , , , |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Springer Nature
2023
|